The role of GATA2 in lethal prostate cancer aggressiveness-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of GATA2 in lethal prostate cancer aggressiveness

Published:2016-11-22 Issue:1 Volume:14 Page:38-48
ISSN:1759-4812
Container-title:Nature Reviews Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Rodriguez-Bravo Veronica,Carceles-Cordon Marc,Hoshida Yujin,Cordon-Cardo Carlos,Galsky Matthew D.,Domingo-Domenech Josep

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/nrurol.2016.225.pdf

Reference138 articles.

1. Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87–108 (2015).

2. Pound, C. R. et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281, 1591–1597 (1999).

3. Klotz, L. et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J. Clin. Oncol. 33, 272–277 (2015).

4. Seidenfeld, J. et al. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann. Intern. Med. 132, 566–577 (2000).

5. Hellerstedt, B. A. & Pienta, K. J. The current state of hormonal therapy for prostate cancer. CA Cancer J. Clin. 52, 154–179 (2002).

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A heritable form of SMARCE1-related meningiomas with clinical implications;Journal of Neuropathology & Experimental Neurology;2024-08-19

2. Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells;Cell Stem Cell;2024-08

3. GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunity;Oncogene;2024-07-27

4. The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer;Frontiers in Pharmacology;2024-07-24

5. Identification of most representative hub-genes for diagnosis, prognosis, and therapies of hepatocellular carcinoma;Chinese Clinical Oncology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3